We once proposed that cell-type-associated chromatin configurations determine cell types and that cancer cell type is determined by cancer-associated chromatin configuration (CACC). In this paper, we hypothesize that flexible cell-typeassociated chromatin configuration is associated with cell potency and has an advantage over inflexible one in regulating genome related activities, such as DNA replication, DNA transcription, DNA repair, and DNA mutagenesis. The reason why cancer is so difficult to treat is because CACC is flexible, which enables cancer cells not only to produce various heterogeneous subclones through limited cell differentiation, but
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for being the cause of cancer heterogeneity [3] [4], but we think that genome instability is only a superficial description about cancer genome, not a mechanism of how cancer heterogeneity is generated. Furthermore, we don't think that heterogeneity is the fundamental obstacle to beating cancer.
More than 30 years ago, we published a hypothesis that abnormal chromatin configuration might be associated with oncogenesis [5] [6] , which has been strongly supported by research evidence [7] [8] . Recently, we published another hypothesis that a group of unknown rivet proteins might be involved in the formation of cell-type-associated chromatin configuration which determines a cell type and that cancer is the cell type that is determined by cancer-associated chromatin configuration (CACC) [9] . Based on this hypothesis, the number of rivet protein fastened-sites in the three-dimensional (3D) genome architecture determines the flexibility of cell-type-associated chromatin configurations.
Compared to normal cell's cell-type-associated chromatin configuration, CACC is more flexible, which might be the fundamental reason why cancer is so difficult to cure. Detailed description about our viewpoints is presented in this paper.
Flexible CACC might be associated with cancer cell
potency and cancer heterogeneity 4 Based on our recently published hypothesis [9] , the flexibility of cell-type-associated chromatin configuration is proportional to cell potency because more flexible chromatin configurations might regulate more gene expressions, and inversely proportional to the number of rivet protein fastened-sites in the 3D genome architecture because more rivet protein fastened-sites in the 3D genome architecture mean more restrictions on the flexibility of cell-type-associated chromatin configuration, for Taken together, at the cellular level, it seems that the reason why most cancers are so difficult to cure is due to cancer heterogeneity, but at the genome architecture level, the reason is due to flexible CACC which enables cancer cells to produce heterogeneous subclones through limited differentiation triggered by environmental changes.
Flexible CACC might have an advantage in regulating genome related activities
In the recent decades, a growing number of studies have shown that chromatin configuration or the 3D genome architecture plays an important role in regulating genome related activities, such as DNA replication, DNA transcription, and DNA repair [11] . This regulation might not be one-way, the genome related activities could also affect dynamic chromatin configuration. We once proposed that chromatin configuration and gene activity might mutually regulate each other, leading to a chain reactionlike regulation pattern during cell cycle progression [6] . Now we think that this type of regulation might also apply to cell differentiation and cell type transition.
We here propose that the flexibility of cell-type-associated chromatin configuration determines not only cell potency but also completely randomly generated, some might be partially randomly generated, i.e., generation of these mutations in genes or noncoding DNA regions is random, but which genes or which segments of noncoding DNA will be mutated is not random but is guided by the dynamic 3D genome architecture. For example, one anticancer drug affects a protein function, which will trigger transcription of this protein's mRNA to produce more such proteins, if the drug effects persist, the transcription activity will carry on, resulting in the formation of a transcription hotspot, which triggers the 3D genome architecture regulation, making the hotspot to move to the region which is suitable for DNA mutagenesis machinery to work , or to make the hotspot regional structure suitable for DNA mutagenesis machinery to work, and thus random mutations are generated within this protein gene.
After natural selection some mutations will be preserved so that the drug's harmful effect is diminished. Therefore, this DNA mutagenesis could be named as the 3D genome architecture guided gene mutagenesis. No doubt, preparation of regional genome structure for triggering DNA mutagenesis machinery to work takes time, for normal cells it will take quite long time In conclusion, flexible CACC enables cancers to undergo limited cell differentiation to generate various subclones and to efficiently use genome related resources to survive environmental changes , which is the fundamental reason why cancer is difficult to cure.
Implications
More than 30 years ago, we proposed that abnormal chromatin configuration might cause cancer and thus turning cancer cell's abnormal chromatin configuration to normal by any means necessary will be able to turn cancer cells back to normal cells [5] . This is the first viewpoint proposed to treat disease (cancer) by manipulating chromatin configuration, which indicates a possibility of developing a novel class of drug, i.e., chromatinconfiguration-manipulating drugs for treating chromatin configuration related diseases. As mentioned above, all cancers might have the same or similar CACC which is formed by cancer-cell-type-specific rivet protein fastened-site pattern in the 3D genome architecture. The unoccupied rivet protein fastened-sites are named as rivet holes which are the structures formed by DNA and related proteins [9] .
If we know the DNA sequence involved in the formation of rivet holes which are involved in the formation of CACC, we can 15 remove or modify this DNA sequence by human embryo DNA editing so that there is no chance to form CACC in the 3D genome architecture of the baby developed from this embryo.
Possibly, in this way, some babies with innate resistance to cancer will be born.
Conclusion
Humans have been fighting cancers for centuries, but at present, most cancers remain unbeatable. Currently, mainstream viewpoints blame cancer heterogeneity for being a major problem in the treatment of cancers. In this paper, we propose that the fundamental reason why most cancers are incurable is because CACC is flexible, which enable cancer cells to efficiently use genome related resources to survive environmental changes.
Hence, to beat cancer, more efforts should be made to restrict the flexibility of CACC or to change CACC so that cancer cells can be turned back to normal or become less malignant.
To support our viewpoints, identification of rivet proteins is critical. We once proposed that Plasmodium falciparum chloroquine resistance marker protein (Pfcrmp) might be one of such rivet proteins because it contains both DNA-binding and histone-binding domains (Q968Y0_PLAFA) [9] . We believe that 
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